Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
S. A. Moghadasi, E. Heilmann, A. Khalil…·R. Harris
The paper identifies SARS-CoV-2 variants resistant to protease inhibitors nirmatrelvir and ensitrelvir, showing pre-existing resistance and potential for spread.